Below you will find our latest news, videos and logos. For more information, please email press@vMocion.com.
Wednesday, March 30, 2016
Mayo Clinic and vMocion Introduce Technology Which Creates the Sensation of Motion, Transforming Virtual Reality
Featuring Mayo Clinic’s Patented Galvanic Vestibular Stimulation (GVS) Technology, vMocion’s 3v™ Platform Now Available for Licensing
LOS ANGELES and SCOTTSDALE, Ariz. – (March 30, 2016) – Mayo Clinic and vMocion, LLC, an entertainment technology company, today announced it is making available Mayo Clinic’s patented Galvanic Vestibular Stimulation (GVS) technology specifically for use in virtual reality and augmented reality. vMocion’s 3v™ Platform (which stands for virtual, vestibular and visual) incorporates this patented GVS technology, which adds a complete sense of three-dimensional movement for the first time into a virtual reality or augmented reality environment. vMocion has been granted the exclusive, global, perpetual license for Mayo Clinic’s GVS patents and algorithms within all media and entertainment categories and will offer the 3v Platform to other media and entertainment companies through a licensing agreement.
This video shares the story behind Mayo Clinic’s patented GVS technology, as well as how the 3v™ Platform works. (Courtesy of Mayo Clinic)
This video features an animation of Mayo Clinic’s patented GVS technology, which creates the sensation of motion by synchronizing what the user is seeing with what they are feeling. (Courtesy of Mayo Clinic)
Brad Hillstrom, M.D. Chairman of vMocion, explains the significance of Mayo Clinic’s GVS technology in redefining the virtual reality experience. (Courtesy of Mayo Clinic)
Bradley Hillstrom, CEO of vMocion, talks about experiencing GVS technology for the first time. (Courtesy of Mayo Clinic)